123rd SIMI National Congress: Kedrion supports the internist community
The company supports a symposium on Sideropenic Anemia
Guelfo Marcucci awards assigned to two young scientists
The award consists of two scholarships assigned to research projects in the field of non-oncological hematology
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
PHARMAMARK, the fifth edition of the Pharmaceutical Marketing Master’s Degree has just ended
The aim of the course, which Kedrion has supported from the first edition, is to train future sector managers
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
SIMTI 2022 Conference: Kedrion alongside the world of blood transfusion
A scientific symposium on Iron deficiency anemia and ferric derisomaltose
Kedrion and IPOPI: the journey continues at the 2022 IPIC
The Primary Immunodeficiencies International Congress took place during World PI Week
Kedrion alongside patients with Neuromuscular Disorders
The Company supports the day dedicated to this group of rare diseases for the fifth consecutive year
Kedrion supports young scientists: awarding the Guelfo Marucci prize
Two scholarships awarded to research projects in the field of non-oncological hematology
“Fabrizio Fabbrizzi” research prizes awarded in Lucca
The initiative was promoted by Kedrion with a contribution by the PPTA